the Financial Results for the period ended December 31, 2025.
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suraksha Diagnostic Limited has filed its financial results with the NSE for the three-month/nine-month period ending December 31, 2025, as required under listing regulations. The detailed figures — including revenue, profit after tax, EBITDA margins, and balance sheet items — would be available in the accompanying results PDF and press release. Without the actual numerical data in this announcement, the specific financial performance cannot be quantified from the filing alone. Investors should refer to the full results document or the company's investor presentation for line-by-line numbers.
This is a routine regulatory filing of periodic financial results, not a one-off corporate action. The stock's near-term reaction will depend entirely on whether the actual reported numbers — revenue growth, margins, and profit — beat or miss street expectations.